generated: '2026-08-26'
method: searched
source: https://nurabio.com/ (full site walked 2026-08-26; no pricing, plans or signup page exists)
plan_count: 0
note: >-
  Nura Bio publishes no plans, no pricing and no commercial API terms, because it sells no API. It is a
  clinical-stage biopharmaceutical company whose product is a drug pipeline (NB-4746 and NB-9402, oral
  SARM1 inhibitors), not software. The content API catalogued in this repo is the WordPress CMS surface
  behind its marketing site: it is free and anonymous because it was never productised, not because a free
  tier was offered. Recorded as an honest zero rather than omitted.
plans: []
evidence:
- url: https://nurabio.com/
  status: 200
  note: >-
    Six-page site. Navigation is Home / About Us / Our Science / News & Literature / Join Us / Contact.
    No pricing, plans, products, developers or signup entry exists anywhere in it.
- url: https://nurabio.com/wp-json/wp/v2/pages?per_page=100
  status: 200
  note: >-
    Authoritative page inventory read from the API itself — exactly 6 published pages, matching the
    navigation. There is no unlinked pricing page.
- url: https://nurabio.com/llms.txt
  status: 200
  note: >-
    The provider's own llms.txt enumerates every page, post and portfolio item on the site. It lists no
    pricing, plans, product or developer page, corroborating the absence from the provider's own account of
    its site.
commercial_posture:
  api_monetised: false
  signup_available: false
  free_tier: 'n/a — no tiers exist'
  detail: >-
    No signup, login, account, trial, quote or contact-sales-for-API path exists. The only contact surface
    is the general corporate form at https://nurabio.com/contact/. Nura Bio's capital comes from venture
    financing — a $73M Series A (2020), a $68M extension past $140M total, and a $73.8M Series B in June
    2026 led by The Column Group with Euclidean Capital, Samsara BioCapital and Sanofi Ventures — not from
    API revenue.